Medtronic plc 2025-2026 Proxy Voting Records

1. Approving, on an advisory basis, the Company's executive compensation;

Meeting held 2025-10-16.

Combines 36 wordings of this item as funds reported it.

93% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 3: The shareholders approved, in a non-binding advisory vote, the compensation awarded to the Company's named executive officers.”): 925,151,188 for, 64,820,280 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 72% for, 5% against (77% of the company cast a for/against vote).

The 1,403 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

Showing the 25 largest of 1,403 asset managers. See all 1,403 in the interactive database.

2. Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;

Meeting held 2025-10-16.

Combines 14 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Proposal 2: The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2026 and to authorize, in a binding vote, the Board of Direct”): 1,006,339,555 for, 101,786,497 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 79% for, 8% against (86% of the company cast a for/against vote).

The 248 asset managers below cast 98% of the shares they voted on this item FOR (403,083,117 for, 6,812,922 against).

Showing the 25 largest of 248 asset managers. See all 248 in the interactive database.

3. Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares;

Meeting held 2025-10-16.

Combines 10 wordings of this item as funds reported it.

98% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 6: The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.”): 1,079,159,483 for, 26,833,237 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 84% for, 2% against (86% of the company cast a for/against vote).

The 245 asset managers below cast 99.9% of the shares they voted on this item FOR (410,674,127 for, 2,809 against).

Showing the 25 largest of 245 asset managers. See all 245 in the interactive database.

4. Renewing the Board of Directors' authority to issue shares under Irish law;

Meeting held 2025-10-16.

Combines 11 wordings of this item as funds reported it.

98% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 4: The shareholders approved renewal of the Board's authority to issue shares under Irish law.”): 1,088,658,571 for, 18,920,739 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 85% for, 1% against (86% of the company cast a for/against vote).

The 244 asset managers below cast 99.6% of the shares they voted on this item FOR (408,542,233 for, 1,517,338 against).

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

5. Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law;

Meeting held 2025-10-16.

Combines 10 wordings of this item as funds reported it.

94% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 5: The shareholders approved renewal of the Board's authority to opt out of pre-emption rights under Irish law.”): 1,035,397,744 for, 71,865,014 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 81% for, 6% against (86% of the company cast a for/against vote).

The 244 asset managers below cast 99.5% of the shares they voted on this item FOR (408,345,376 for, 1,688,677 against).

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

6. Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves;

Meeting held 2025-10-16.

Combines 13 wordings of this item as funds reported it.

99.8% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 7: The shareholders approved an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves.”): 988,783,308 for, 1,421,542 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 77% for, 0.2% against (77% of the company cast a for/against vote).

The 244 asset managers below cast 99.9% of the shares they voted on this item FOR (409,881,284 for, 147 against).

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

7. Approving amendments to the Company's Articles of Association, to update the advance notice provisions.

Meeting held 2025-10-16.

Combines 11 wordings of this item as funds reported it.

99.4% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 9: The shareholders approved amendments to the Company's Articles of Association to update the advance notice provisions.”): 984,572,748 for, 5,648,332 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 77% for, 0.5% against (77% of the company cast a for/against vote).

The 244 asset managers below cast 99.7% of the shares they voted on this item FOR (408,875,571 for, 1,005,861 against).

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

8. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III

Meeting held 2025-10-16.

Combines 20 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Randall J. Hogan, III”): 974,218,474 for, 16,327,778 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 76% for, 1% against (77% of the company cast a for/against vote).

The 243 asset managers below cast 99.8% of the shares they voted on this item FOR (409,330,342 for, 438,144 against).

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

9. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Joon S. Lee, M.D.

Meeting held 2025-10-16.

Combines 21 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Joon S. Lee, M.D.”): 984,707,922 for, 5,824,405 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 77% for, 0.5% against (77% of the company cast a for/against vote).

The 243 asset managers below cast 99.9% of the shares they voted on this item FOR (409,514,704 for, 253,778 against).

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

10. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D.

Meeting held 2025-10-16.

Combines 21 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Elizabeth G. Nabel, M.D.”): 941,510,879 for, 49,104,608 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 73% for, 4% against (77% of the company cast a for/against vote).

The 243 asset managers below cast 99.8% of the shares they voted on this item FOR (408,977,638 for, 790,854 against).

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

11. Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and

Meeting held 2025-10-16.

Combines 10 wordings of this item as funds reported it.

99.7% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 8: The shareholders approved a Capital Reduction to Create Distributable Reserves under Irish Law.”): 1,104,381,417 for, 2,641,267 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 86% for, 0.3% against (86% of the company cast a for/against vote).

The 243 asset managers below cast 99.9% of the shares they voted on this item FOR (409,772,950 for, 138 against).

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

12. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold

Meeting held 2025-10-16.

Combines 15 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Craig Arnold”): 860,168,749 for, 129,336,374 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 67% for, 10% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99% of the shares they voted on this item FOR (404,298,441 for, 5,389,535 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

13. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly

Meeting held 2025-10-16.

Combines 18 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Scott C. Donnelly”): 953,977,029 for, 36,527,587 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 74% for, 3% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.8% of the shares they voted on this item FOR (408,975,246 for, 728,589 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

14. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca

Meeting held 2025-10-16.

Combines 18 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Lidia L. Fonseca”): 957,039,072 for, 32,793,740 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 75% for, 3% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.8% of the shares they voted on this item FOR (409,022,546 for, 681,216 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

15. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): John P. Groetelaars

Meeting held 2025-10-16.

Combines 17 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: John P. Groetelaars”): 977,157,923 for, 13,337,052 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 76% for, 1% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.9% of the shares they voted on this item FOR (409,664,975 for, 38,857 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

16. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): William R. Jellison

Meeting held 2025-10-16.

Combines 18 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: William R. Jellison”): 984,922,865 for, 5,565,192 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 77% for, 0.5% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.9% of the shares they voted on this item FOR (409,701,943 for, 1,890 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

17. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis

Meeting held 2025-10-16.

Combines 18 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Gregory P. Lewis”): 972,648,057 for, 17,845,085 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 76% for, 1% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.8% of the shares they voted on this item FOR (409,272,831 for, 431,003 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

18. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton

Meeting held 2025-10-16.

Combines 18 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Kevin E. Lofton”): 979,276,656 for, 11,217,586 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 76% for, 0.9% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.9% of the shares they voted on this item FOR (409,330,893 for, 372,942 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

19. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha

Meeting held 2025-10-16.

Combines 16 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Geoffrey S. Martha”): 928,147,564 for, 62,347,780 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 72% for, 5% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 99.8% of the shares they voted on this item FOR (408,923,003 for, 751,506 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

20. Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell

Meeting held 2025-10-16.

Combines 16 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

Medtronic plc’s own tally for this item (“Elect Director: Kendall J. Powell”): 890,393,677 for, 98,996,461 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,281,869,213 outstanding shares: 69% for, 8% against (77% of the company cast a for/against vote).

The 242 asset managers below cast 97% of the shares they voted on this item FOR (396,184,358 for, 13,581,128 against).

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

21. Approving, on an advisory basis, the Company's executive compensation.

Meeting held 2024-10-17 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

93% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 3: The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company's named executive officers.”): 924,541,222 for, 70,301,925 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 72% for, 5% against (78% of the company cast a for/against vote).

The 7 asset managers below cast 97% of the shares they voted on this item FOR (159,646 for, 5,494 against).

22. Amend Articles/Charter to Reflect Changes in Capital

Meeting held 2025-10-16.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

The 4 asset managers below cast 100% of the shares they voted on this item FOR (96,182 for, 0 against).

23. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): CRAIG ARNOLD &QUOT

Meeting held 2025-10-16.

0% fund support · no official result

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 64,645 against).

24. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): GEOFFREY S. MARTHA &QUOT

Meeting held 2025-10-16.

0% fund support · no official result

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 64,645 against).

25. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): GREGORY P. LEWIS &QUOT

Meeting held 2025-10-16.

100% fund support · no official result

The 4 asset managers below cast 100% of the shares they voted on this item FOR (64,645 for, 0 against).

26. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): JOHN P. GROETELAARS &QUOT

Meeting held 2025-10-16.

100% fund support · no official result

The 4 asset managers below cast 100% of the shares they voted on this item FOR (64,645 for, 0 against).

27. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): KENDALL J. POWELL &QUOT

Meeting held 2025-10-16.

0% fund support · no official result

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 64,645 against).

28. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): KEVIN E. LOFTON &QUOT

Meeting held 2025-10-16.

0% fund support · no official result

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 64,645 against).

29. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): LIDIA L. FONSECA &QUOT

Meeting held 2025-10-16.

100% fund support · no official result

The 4 asset managers below cast 100% of the shares they voted on this item FOR (64,645 for, 0 against).

30. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): SCOTT C. DONNELLY &QUOT

Meeting held 2025-10-16.

6% fund support · no official result

The 4 asset managers below cast 6% of the shares they voted on this item FOR (3,756 for, 60,889 against).

31. ELECTION OF DIRECTOR TO HOLD OFFICE UNTIL THE 2026 ANNUAL GENERAL MEETING OF MEDTRONIC PLC (THE COMPANY&QUOT): WILLIAM R. JELLISON &QUOT

Meeting held 2025-10-16.

100% fund support · no official result

The 4 asset managers below cast 100% of the shares they voted on this item FOR (64,645 for, 0 against).

32. Adopt Advance Notice Requirement

Meeting held 2025-10-16.

99.4% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 9: The shareholders approved amendments to the Company's Articles of Association to update the advance notice provisions.”): 984,572,748 for, 5,648,332 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 77% for, 0.5% against (77% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (13,338 for, 0 against).

33. Approve Article Amendments

Meeting held 2025-10-16.

100% fund support · no official result

The 3 asset managers below cast 100% of the shares they voted on this item FOR (13,338 for, 0 against).

34. Election of Directors (Majority Voting)

Meeting held 2025-10-16.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

The 3 asset managers below cast 100% of the shares they voted on this item FOR.

35. Eliminate Pre-Emptive Rights

Meeting held 2025-10-16.

94% Passed · of votes cast

Medtronic plc’s own tally for this item (“Proposal 5: The shareholders approved renewal of the Board's authority to opt out of pre-emption rights under Irish law.”): 1,035,397,744 for, 71,865,014 against — passed, per its Form 8-K (Item 5.07). Of all 1,281,869,213 outstanding shares: 81% for, 6% against (86% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (13,338 for, 0 against).

36. Miscellaneous Corporate Actions

Meeting held 2025-10-16.

100% fund support · no official result

The 3 asset managers below cast 100% of the shares they voted on this item FOR (13,338 for, 0 against).

37. Stock Issuance

Meeting held 2025-10-16.

100% fund support · no official result

The 3 asset managers below cast 100% of the shares they voted on this item FOR (13,338 for, 0 against).

38. Approving, on an advisory basis, the Company's executive compensation

Reported under meeting date 2025-08-22; no official results on file for that date.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

The 2 asset managers below cast 100% of the shares they voted on this item FOR (4,063,132 for, 0 against).

39. Director Elections

Meeting held 2025-10-16.

100% fund support · no official result

The 2 asset managers below cast 100% of the shares they voted on this item FOR (604 for, 0 against).